⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1080461 | 1.00 | — | — | |
| SCHEMBL834755 | 1.00 | — | — | |
| SCHEMBL23113010 | 0.76 | — | — | |
| SCHEMBL1033028 | 0.71 | — | — | |
| SCHEMBL8829614 | 0.69 | — | — | |
| SCHEMBL9615377 | 0.69 | — | — | |
| SCHEMBL9347949 | 0.69 | — | — | |
| SCHEMBL6566455 | 0.67 | — | — | |
| SCHEMBL10400486 | 0.64 | — | — | |
| SCHEMBL2398211 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192622-A1 | ANTI-SARS-COV-2 DRUG | ONCOLYS BIOPHARMA, INC. (JP) | 2023-06-22 | — | — | US | disclosed |
| EP-4154884-A1 | ANTI-SARS-COV-2 DURG | Oncolys BioPharma, Inc. (JP) | 2023-03-29 | — | — | EP | disclosed |
| US-11371067-B2 | Transaminase reactions | CODEXIS, INC. (US) | 2022-06-28 | — | — | US | disclosed |
| CN-109476680-B | Organic magnesium phosphide, process for producing the same, complex thereof, process for producing the same, and process for producing organic phosphorus compound using the same | 北兴化学工业株式会社 | 2022-06-28 | — | — | CN | disclosed |
| US-20200362377-A1 | TRANSAMINASE REACTIONS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2020-11-19 | — | — | US | disclosed |
| US-10767202-B2 | Transaminase reactions | CODEXIS, INC. (US) | 2020-09-08 | — | — | US | disclosed |
| US-10407378-B2 | Compound, and flavor and/or fragrance composition containing said compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2019-09-10 | — | — | US | disclosed |
| US-20190248815-A1 | ORGANIC MAGNESIUM PHOSPHIDE AND MANUFACTURING METHOD THEREOF, ORGANIC MAGNESIUM PHOSPHIDE COMPLEX AND MANUFACTURING METHOD THEREOF, AND MANUFACTURING METHOD OF ORGANIC PHOSPHORUS COMPOUND USING SAID PHOSPHIDE | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2019-08-15 | — | — | US | disclosed |
| EP-3480204-A1 | ORGANIC MAGNESIUM PHOSPHIDE AND METHOD FOR PRODUCING SAME, ORGANIC MAGNESIUM PHOSPHIDE COMPLEX AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING ORGANIC PHOSPHORUS-CONTAINING COMPOUND USING SAID PHOSPHIDE | Hokko Chemical Industry Co., Ltd. (JP) | 2019-05-08 | — | — | EP | disclosed |
| US-20190040431-A1 | TRANSAMINASE REACTIONS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2019-02-07 | — | — | US | disclosed |
| US-20020193421-A1 | Compounds having retinoid-like activity | BRISTOL-MYERS SQUIBB COMPANY | 2002-12-19 | — | — | US | disclosed |
| EP-0877730-B1 | ARYL ACRYLICS FOR USE AS FUNGICIDE | MONSANTO TECHNOLOGY LLC (US) | 2002-10-02 | — | — | EP | disclosed |
| WO-2002065984-A2 | COMPOUNDS HAVING RETINOID-LIKE ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-08-29 | — | — | WO | disclosed |
| WO-2000059861-A1 | SELECTIVE RETINOIC ACID ANALOGS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-10-12 | — | — | WO | disclosed |
| US-5945561-A | ANTIINFLAMMATORY AGENT, RHEUMATIC DISORDERS, SKIN DISORDERS,ANTISCARRING AGENT | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-08-31 | — | — | US | disclosed |
| WO-1998049136-A1 | RETINOID-LIKE COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-11-05 | — | — | WO | disclosed |
| US-5739140-A | AGRICULTURAL FUNGICIDES | MONSANTO COMPANY (US) | 1998-04-14 | — | — | US | disclosed |
| WO-1997016413-A9 | ARYL ACRYLICS FOR USE AS FUNGICIDE | — | 1997-08-14 | — | — | WO | disclosed |
| US-4755598-A | 1'-(substituted)ethyl-7β-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylate derivatives having antibacterial utility | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1988-07-05 | — | — | US | disclosed |
| EP-0128028-A2 | Cephalosporin derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1984-12-12 | — | — | EP | disclosed |